Tirzepatide is administered as a once-weekly subcutaneous injection, starting at 2.5 mg for treatment initiation, with maintenance doses ranging from 5 mg to 15 mg depending on the indication and individual patient response
Weight loss tends to lower blood pressure long-term, so its not a major issue, but if you already have high blood pressure, keep an eye on it
These take longer to digest and can lead to significant discomfort when combined with the peak levels of tirzepatide
For lysis and Ni-NTA affinity purification, His-lysis buffer (50 mM PBS buffer, pH 7.4, 20 mM imidazole, 0.1% Tween 20) was used
These are the non-negotiables, he says